The major biogenic amine metabolites in mood disorders

被引：0
作者：
Yang, Jingyi [1 ]
Yuan, Minlan [1 ]
Zhang, Wei [1 ,2 ,3 ]
机构：
[1] Sichuan Univ, West China Hosp, Mental Hlth Ctr, Psychiat Lab,State Key Lab Biotherapy, Chengdu, Peoples R China
[2] Sichuan Univ, West China Hosp, West China Biomed Big Data Ctr, Chengdu, Peoples R China
[3] Sichuan Univ, Big Data Ctr, Chengdu, Peoples R China
来源：
FRONTIERS IN PSYCHIATRY | 2024年 / 15卷
关键词：
mood disorder; major depressive disorder; bipolar disorder; metabolite; biogenic amine; HISTAMINE H-3 RECEPTOR; CREATINE MONOHYDRATE AUGMENTATION; KYNURENINE PATHWAY METABOLITES; DEPRESSIVE-LIKE BEHAVIORS; BIPOLAR DISORDER; GUT MICROBIOTA; DOUBLE-BLIND; ADOLESCENT DEPRESSION; NEUROTROPHIC FACTOR; FEMALE ADOLESCENTS;
D O I：
10.3389/fpsyt.2024.1460631
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Mood disorders, including major depressive disorder and bipolar disorder, have a profound impact on more than 300 million people worldwide. It has been demonstrated mood disorders were closely associated with deviations in biogenic amine metabolites, which are involved in numerous critical physiological processes. The peripheral and central alteration of biogenic amine metabolites in patients may be one of the potential pathogeneses of mood disorders. This review provides a concise overview of the latest research on biogenic amine metabolites in mood disorders, such as histamine, kynurenine, and creatine. Further studies need larger sample sizes and multi-center collaboration. Investigating the changes of biogenic amine metabolites in mood disorders can provide biological foundation for diagnosis, offer guidance for more potent treatments, and aid in elucidating the biological mechanisms underlying mood disorders.
引用
收藏
页数：14
相关论文
共 50 条
  • [21] Pathologic role of nitrergic neurotransmission in mood disorders
    Ghasemi, Mehdi
    Claunch, Joshua
    Niu, Kathy
    PROGRESS IN NEUROBIOLOGY, 2019, 173 : 54 - 87
  • [22] Neuropsychological Abnormalities in Schizophrenia and Major Mood Disorders: Similarities and Differences
    Barch, Deanna M.
    CURRENT PSYCHIATRY REPORTS, 2009, 11 (04) : 313 - 319
  • [23] Epilepsy and mood disorders
    Kanner, Andres M.
    EPILEPSIA, 2007, 48 : 20 - 22
  • [24] Cannabidiol as a Treatment for Mood Disorders: A Systematic Review
    Pinto, Jairo Vinicius
    Saraf, Gayatri
    Frysch, Christian
    Vigo, Daniel
    Keramatian, Kamyar
    Chakrabarty, Trisha
    Lam, Raymond W.
    Kauer-Sant'Anna, Marcia
    Yatham, Lakshmi N.
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2020, 65 (04): : 213 - 227
  • [25] Effect of lithium maintenance on suicidal behavior in major mood disorders
    Tondo, L
    Jamison, KR
    Baldessarini, RJ
    NEUROBIOLOGY OF SUICIDE: FROM THE BENCH TO THE CLINIC, 1997, 836 : 339 - 351
  • [26] Genomic studies of mood disorders - the brain as a muscle?
    Alexander B Niculescu
    Genome Biology, 6
  • [27] Inflammation as a treatment target in mood disorders: review
    Jones, Brett D. M.
    Daskalakis, Zafiris J.
    Carvalho, Andre F.
    Strawbridge, Rebecca
    Young, Allan H.
    Mulsant, Benoit H.
    Husain, M. Ishrat
    BJPSYCH OPEN, 2020, 6 (04):
  • [28] Diet and Neurocognition in Mood Disorders - An Overview of the Overlooked
    Balanza-Martinez, Vicent
    Shansis, Flavio M.
    Tatay-Manteiga, Amparo
    Lopez-Garcia, Pilar
    CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (20) : 2353 - 2362
  • [29] Potential Use of Stem Cells in Mood Disorders
    Colpo, Gabriela D.
    Stertz, Laura
    Diniz, Breno S.
    Teixeira, Antonio L.
    CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 2: APPROACHES FOR DIVERSE DISEASES AND CONDITIONS, 2018, 1089 : 87 - 96
  • [30] Neurocircuitry of Mood Disorders
    Joseph L Price
    Wayne C Drevets
    Neuropsychopharmacology, 2010, 35 : 192 - 216
12345